Terumo Cardiovascular Systems announced that it has entered into an exclusive agreement with Livermore, Calif.-based LAAx Inc. to distribute the TigerPaw System II, a left atrial appendage closure device in the U.S.
Ann Arbor-based Terumo Heart Inc., a wholly owned subsidiary of Japan’s Terumo Corp., Tuesday announced that a patient implanted with the DuraHeart Left Ventricular Assist System has surpassed five years of support on the mechanical circulatory support device.
Ann Arbor-based Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph Plus Endoscopic Vessel Harvesting System following clearance by the United States Food and Drug Administration. Based on the successful platform of the VirtuoSaph […]
Ann Arbor-based Terumo Heart Inc., a subsdiary of Japan’s Terumo Corp., Wednesday announced that another patient implanted with the DuraHeart Left Ventricular Assist System has surpassed four years after receiving the mechanical circulatory support device. […]